CorMedix Financial Statements From 2010 to 2025

CorMedix Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 124.8 M 118.8 M 40 M Slightly volatile Short and Long Term Debt Total 491.2 K 517 K 3.3 M Slightly volatile Other Current Liabilities 33.5 M 32 M 6.5 M Slightly volatile Total Current Liabilities 35.5 M 33.8 M 9 M Slightly volatile Property Plant And Equipment Net 2.4 M 2.3 M 866.2 K Slightly volatile Accounts Payable 1.7 M 1.7 M 1.7 M Slightly volatile Cash 42.7 M 40.7 M 21.3 M Slightly volatile Non Current Assets Total 4.5 M 4.3 M 1.2 M Slightly volatile Cash And Short Term Investments 28 M 51.7 M 28.2 M Slightly volatile Common Stock Shares Outstanding 61.8 M 58.9 M 22.3 M Slightly volatile Other Current Assets 3.8 M 3.6 M 1 M Slightly volatile Other Stockholder Equity 445.3 M 424.1 M 200.9 M Slightly volatile Total Liabilities 35.9 M 34.2 M 9.9 M Slightly volatile Total Current Assets 120.3 M 114.6 M 38.9 M Slightly volatile Short Term Debt 159.5 K 167.9 K 842.3 K Slightly volatile Common Stock 38.3 K 64.4 K 38.6 K Slightly volatile Property Plant Equipment 2.9 M 2.7 M 856.4 K Slightly volatile Common Stock Total Equity 36.2 K 43.8 K 35.8 K Slightly volatile Property Plant And Equipment Gross 3.1 M 3 M 1 M Slightly volatile Other Liabilities 31.5 K 33.2 K 357.7 K Pretty Stable Capital Surpluse 372.3 M 354.6 M 187.9 M Slightly volatile Current Deferred Revenue 1.9 K 2 K 24.6 K Pretty Stable Net Invested Capital 49.3 M 84.7 M 28.7 M Slightly volatile Net Working Capital 47.9 M 80.7 M 27.8 M Slightly volatile Long Term Debt Total 4.9 M 5.5 M 6 M Slightly volatile Capital Stock 42.3 K 64.5 K 80.4 K Slightly volatile Capital Lease Obligations 723.5 K 517 K 293.4 K Slightly volatile Non Current Liabilities Other 633.9 K 922.8 K 307.2 K Slightly volatile
CorMedix Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 480.2 K 457.4 K 177.7 K Very volatile Interest Expense 34.6 K 36.4 K 439.4 K Slightly volatile Selling General Administrative 31.5 M 30 M 12.2 M Slightly volatile Other Operating Expenses 69.1 M 65.8 M 26.5 M Slightly volatile Research Development 3.7 M 3.9 M 9.1 M Slightly volatile Total Operating Expenses 65.8 M 62.6 M 25.9 M Slightly volatile Preferred Stock And Other Adjustments 28.3 K 29.8 K 123.5 K Slightly volatile Interest Income 2.7 M 2.6 M 585 K Slightly volatile Reconciled Depreciation 325.3 K 309.8 K 88.9 K Slightly volatile Selling And Marketing Expenses 25.8 M 28.7 M 19.3 M Slightly volatile
CorMedix Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation 325.3 K 309.8 K 142.8 K Pretty Stable Other Non Cash Items 270.4 K 284.6 K 1.8 M Pretty Stable Total Cash From Financing Activities 23.5 M 26.3 M 23.3 M Slightly volatile End Period Cash Flow 42.8 M 40.8 M 21.4 M Slightly volatile Stock Based Compensation 6.4 M 6.1 M 2.8 M Slightly volatile Begin Period Cash Flow 46 M 43.8 M 19.5 M Slightly volatile Change To Netincome 3.4 M 4.8 M 3.1 M Pretty Stable Issuance Of Capital Stock 33.1 M 18.9 M 26.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 11.98 12.61 2.5 K Slightly volatile Dividend Yield 0.0179 0.0202 0.022 Slightly volatile Days Sales Outstanding 524 499 281 Very volatile Average Payables 1.4 M 2 M 1.7 M Slightly volatile Stock Based Compensation To Revenue 0.15 0.16 177 Slightly volatile Capex To Depreciation 0.35 0.3736 3.5059 Very volatile EV To Sales 10.98 11.55 2.1 K Slightly volatile Inventory Turnover 0.4 0.4198 4.2665 Pretty Stable Days Of Inventory On Hand 626 869 838 Slightly volatile Payables Turnover 1.95 1.8548 0.4689 Slightly volatile Sales General And Administrative To Revenue 0.75 0.79 447 Slightly volatile Average Inventory 995.2 K 947.9 K 486.1 K Slightly volatile Research And Ddevelopement To Revenue 0.0991 0.1 188 Slightly volatile Capex To Revenue 0.0029 0.0031 5.2399 Slightly volatile Cash Per Share 0.83 0.878 1.9316 Slightly volatile Days Payables Outstanding 187 197 15.6 K Pretty Stable Income Quality 2.96 2.8229 1.0126 Slightly volatile Intangibles To Total Assets 0.0124 0.014 0.0152 Slightly volatile Current Ratio 3.98 3.3858 5.1753 Slightly volatile Receivables Turnover 0.72 0.76 13.7218 Pretty Stable Capex Per Share 0.0019 0.002 0.0074 Very volatile Average Receivables 24.4 M 23.2 M 6.3 M Slightly volatile Revenue Per Share 0.7 0.66 0.1431 Slightly volatile Interest Debt Per Share 0.0089 0.0094 5.9672 Slightly volatile Debt To Assets 0.0041 0.0044 0.6048 Slightly volatile Operating Cycle 754 1.3 K 1 K Slightly volatile Days Of Payables Outstanding 187 197 15.6 K Pretty Stable Ebt Per Ebit 1.34 0.8644 1.2122 Slightly volatile Quick Ratio 3.92 3.1613 5.0972 Slightly volatile Net Income Per E B T 0.73 0.84 0.8293 Very volatile Cash Ratio 1.14 1.2013 3.2733 Slightly volatile Days Of Inventory Outstanding 626 869 838 Slightly volatile Days Of Sales Outstanding 524 499 281 Very volatile Free Cash Flow Operating Cash Flow Ratio 0.81 1.0023 0.9962 Slightly volatile Fixed Asset Turnover 17.7 16.86 4.6149 Slightly volatile Debt Ratio 0.0041 0.0044 0.6048 Slightly volatile Price Sales Ratio 11.98 12.61 2.5 K Slightly volatile Asset Turnover 0.35 0.33 0.0729 Slightly volatile
CorMedix Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 500.7 M 476.9 M 146 M Slightly volatile Enterprise Value 458.6 M 436.7 M 124.8 M Slightly volatile

CorMedix Fundamental Market Drivers

CorMedix Upcoming Events

About CorMedix Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:

How To Invest In CorMedix Details

Is CorMedix Stock a good investment? Details

What is CorMedix's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details